Retroperitoneale Lymphadenektomie bei Hodentumoren

Albers P, Siener R, Kliesch S et al. (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group trial. J Clin Oncol 21: 1505–1512

Heidenreich A, Sesterhenn IA, Mostofi FK et al. (1998) Prognostic factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83: 1002–1011

Ondrus D, Matoska J, Belan V et al. (1998) Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment. Eur Urol 33: 562–566

Read G, Stenning SP, Cullen MH et al. (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10: 1762–1768

Klepp O, Dahl O, Flodgren P et al. (1997) Risk-adapted treatment of clinical stage I non-seminoma testis cancer. Eur J Cancer 33: 1038–1044

Schmoll H-J, Souchon R, Krege S et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15: 1377–1399

Weißbach L, Boedefeld EA, Horstmann-Dubral B et al. (1990) Surgical treatment of stage I non-seminomatous germ cell testis tumor. Eur Urol 17: 97–106

Donohue JP, Thornhill JA, Foster RS et al. (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965–1989): modifications of technique and impact on ejaculation. J Urol 149: 237–243

Rassweiler JJ, Frede T, Lenz E et al. (2000) Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low – stage testis cancer. Eur Urol 37: 251–260

Hsu TH, Su LM, Ong A (2003) Anterior extraperitoneal approach to laparoscopic retroperitoneal lymph node dissection: a novel technique. J Urol 169: 258–260

Steiner H, Peschel R, Janetschek G et al. (2004) Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology 62: 550–555

Hara I, Kawabata G, Yamada Y et al. (2004) Extraperitoneal laparoscopic retroperitoneal lymph node dissection in supine position after chemotherapy for advanced testicular carcinoma. Int J Urol 11: 934–939

Nelson JB, Chen RN, Bishoff JT et al. (1999) Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 54: 1064–1967

Corvin S, Sturm W, Kuczyk M et al. (2005) Laparoscopic retroperitoneal lymphadenectomy in the management of low – stage testicular cancer: technique and results. Minim Invasive Ther Allied Technol 14: 52–56

Corvin S, Sturm W, Schlatter E et al. (2005) Laparoscopic retroperitoneal lymph-node dissection with the waterjet is technically feasible and safe in testis-cancer patient. J Endourol 19: 823–882

Corvin S, Kuczyk M, Anastasiadis A, Stenzl A (2004) Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. World J Urol 22: 33–36

Peschel R, Gettman MT, Neururer R et al. (2002) Laparoscopic retroperitoneal lymph node dissection: descriptionof the nerve – sparing technique. Urology 60: 339–343

Janetschek G, Hobisch A, Peschel R et al. (2000) Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: Long-term outcome J Urol 163: 1793–1796

Höltl L, Peschel R, Knapp R et al. (2002) Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology 59: 114–118

Janetschek G, Hobisch A, Hittmair A et al. (1999) Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol 151: 477–481

Rassweiler JJ, Seemann O, Henkel TO et al. (1996) Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: Indications and limitations. J Urol 156: 1108–1113

Albers P, Weißbach L, Krege S et al. (2004) Prediction of necrosis after chemotherapy of advanced germ cell tumors – results of a prospective multicenter trial of the GTCSG. J Urol 171: 1835–1838

Wit M de, Hartmann M, Brenner W et al. (2006) (18F)-FDG-PET in germ cell tumors following chemotherapy: Results of the German multicenter trial. JCO 24: 222; Abstr. 4521

De Santis M, Bokemeyer C, Becherer A et al. (2001) Predictive impact of 2–18 fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 19: 3740–3744

Rabbani F, Goldenberg SL, Gleave ME et al. (1998) Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of the residual mass sufficient? Br J Urol 81: 295–300

Sheinfeld J (2002) The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. Semin Urol Oncol 20: 262–271

Palese MA, Su LM, Kavoussi LR (2002) Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 60: 130–134

Schmoll HJ, Beyer J (1998) Prognostic factors in metastatic germ cell tumors. Semin Oncol 25: 174–185